Treace Medical Concepts upgraded by BTIG Research with a new price target
$TMCI
Medical/Dental Instruments
Health Care
BTIG Research upgraded Treace Medical Concepts from Neutral to Buy and set a new price target of $16.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/4/2025 | $16.00 | Neutral → Buy | BTIG Research |
| 12/31/2024 | $14.50 | Buy | Lake Street |
| 12/17/2024 | $8.00 | Neutral | Analyst |
| 5/16/2024 | $16.00 → $6.50 | Buy → Neutral | UBS |
| 5/8/2024 | $15.00 → $5.50 | Overweight → Equal-Weight | Morgan Stanley |
| 5/8/2024 | $17.00 → $7.00 | Buy → Hold | Truist |
| 5/8/2024 | $15.00 → $6.00 | Buy → Hold | Stifel |
| 5/8/2024 | $15.00 → $8.00 | Overweight → Neutral | JP Morgan |
8-K - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Filer)
SCHEDULE 13G - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Subject)
SCHEDULE 13G/A - TREACE MEDICAL CONCEPTS, INC. (0001630627) (Subject)